Sanguinarine is an allosteric activator of AMP-activated protein kinase
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Jiwon | - |
dc.contributor.author | He, Ningning | - |
dc.contributor.author | Sung, Mi-Kyung | - |
dc.contributor.author | Yang, Young | - |
dc.contributor.author | Yoon, Sukjoon | - |
dc.date.available | 2021-02-22T11:01:31Z | - |
dc.date.issued | 2011-09 | - |
dc.identifier.issn | 0006-291X | - |
dc.identifier.issn | 1090-2104 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/6944 | - |
dc.description.abstract | We found that a natural product, Sanguinarine, directly interacts with AMPK and enhances its enzymatic activity. Cell-based assays confirmed that cellular AMPK and the downstream acetyl-CoA carboxylase (ACC) were phosphorylated after Sanguinarine treatment. Sanguinarine was shown to exclusively activate AMPK holoenzymes containing alpha 1 gamma 1 complexes, and it activated both beta 1- and beta 2-containing isotypes of AMPK. Furthermore, a docking study suggested that Sanguinarine binds AMPK at the cleft between the beta and gamma domains whereas the physiological activator, AMP, binds at the well-characterized gamma domain pocket. In summary, we report that Sanguinarine is a novel, direct activator of AMPK that binds by a unique allosteric mechanism different from that of the natural AMPK ligand, AMP, and other known AMPK activators. These studies have direct applications to the pharmacological study of AMPK activation and the potential development of new therapeutics. (C) 2011 Elsevier Inc. All rights reserved. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.title | Sanguinarine is an allosteric activator of AMP-activated protein kinase | - |
dc.type | Article | - |
dc.publisher.location | United States | - |
dc.identifier.doi | 10.1016/j.bbrc.2011.08.081 | - |
dc.identifier.scopusid | 2-s2.0-80053115768 | - |
dc.identifier.wosid | 000295443400019 | - |
dc.identifier.bibliographicCitation | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, v.413, no.2, pp 259 - 263 | - |
dc.citation.title | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - |
dc.citation.volume | 413 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 259 | - |
dc.citation.endPage | 263 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biophysics | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biophysics | - |
dc.subject.keywordPlus | UPSTREAM KINASE | - |
dc.subject.keywordPlus | GLUCOSE-UPTAKE | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | SUBUNIT | - |
dc.subject.keywordPlus | MECHANISM | - |
dc.subject.keywordPlus | INSULIN | - |
dc.subject.keywordPlus | BINDING | - |
dc.subject.keywordPlus | BETA | - |
dc.subject.keywordPlus | SNF1 | - |
dc.subject.keywordPlus | CHELERYTHRINE | - |
dc.subject.keywordAuthor | Sanguinarine | - |
dc.subject.keywordAuthor | AMPK | - |
dc.subject.keywordAuthor | Allosteric activator | - |
dc.subject.keywordAuthor | Energy metabolism | - |
dc.subject.keywordAuthor | Diabetes | - |
dc.subject.keywordAuthor | Obesity | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S0006291X11014811 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.